peg-interferon alfa-2b stable pharmaceutical composition

摘要

Stable peg-interferon alfa-2b pharmaceutical composition The present invention relates to stable pharmaceutical compositions comprising peg-interferon alga-2b. more particularly, it relates to stable pharmaceutical compositions comprising peg-interferone alpha-2b and cryoprotectant selected from the group consisting of 2-hydroxy-propyl-beta-cyclodextrin, sucralose or poly (vinyl pyrrolidone) 4000. it also refers to the methods of manufacture of the composition, the method of administration and kits containing them.